Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome
Article in PLOS ONE (April 2024)
The most recent citing publications are shown below. View all 250 publications that cite this research output on Dimensions.
Article in PLOS ONE (April 2024)
Preprint in medRxiv (April 2024)
Article in Frontiers in Microbiology (March 2024)